Apellis Pharmaceuticals
APLS
APLS
267 hedge funds and large institutions have $2.77B invested in Apellis Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 91 increasing their positions, 90 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 90
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
7.83% less ownership
Funds ownership: 104.72% → 96.88% (-7.8%)
Holders
267
Holding in Top 10
4
Calls
$102M
Puts
$21.1M
Top Buyers
| 1 | +$38.2M | |
| 2 | +$29.4M | |
| 3 | +$25.8M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$22.6M |
| 5 |
IG
ING Group
Amsterdam,
Netherlands
|
+$19.6M |
Top Sellers
| 1 | -$191M | |
| 2 | -$52.2M | |
| 3 | -$33.7M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$29.5M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$23.6M |
